These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 23084592)

  • 21. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors.
    Ehret GB; Voide C; Gex-Fabry M; Chabert J; Shah D; Broers B; Piguet V; Musset T; Gaspoz JM; Perrier A; Dayer P; Desmeules JA
    Arch Intern Med; 2006 Jun; 166(12):1280-7. PubMed ID: 16801510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of methadone treatment on cardiac repolarization and conduction in opioid users.
    Martell BA; Arnsten JH; Krantz MJ; Gourevitch MN
    Am J Cardiol; 2005 Apr; 95(7):915-8. PubMed ID: 15781034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methadone-associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program.
    Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Walroth TA; Ott CA; Desta Z; Williams G; Moe PR; Wilbrandt M; Tisdale JE
    Pharmacotherapy; 2021 Mar; 41(3):238-246. PubMed ID: 33345336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid maintenance patients with QTc prolongation: congenital long QT syndrome mutation may be a contributing risk factor.
    Anchersen K; Hansteen V; Gossop M; Clausen T; Waal H
    Drug Alcohol Depend; 2010 Dec; 112(3):216-9. PubMed ID: 20702049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender-specific differences in susceptibility to low-dose methadone-associated QTc prolongation in patients with heroin dependence.
    Chang KC; Huang CL; Liang HY; Chang SS; Wang YC; Liang WM; Lane HY; Chen CH; Stephen Huang SK
    J Cardiovasc Electrophysiol; 2012 May; 23(5):527-33. PubMed ID: 22136144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
    Pearson EC; Woosley RL
    Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study.
    Fareed A; Vayalapalli S; Scheinberg K; Gale R; Casarella J; Drexler K
    Am J Drug Alcohol Abuse; 2013 Jul; 39(4):235-40. PubMed ID: 23808912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methadone-induced long QT syndrome vs methadone-induced torsades de pointes.
    Justo D
    Arch Intern Med; 2006 Nov; 166(20):2288; author reply 2289-90. PubMed ID: 17101953
    [No Abstract]   [Full Text] [Related]  

  • 29. Prolonged QT interval by methadone: relevance for daily practice? A prospective study in patients with cancer and noncancer pain.
    van den Beuken-van Everdingen MH; Geurts JW; Patijn J
    J Opioid Manag; 2013; 9(4):263-7. PubMed ID: 24353019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes.
    Krantz MJ; Kutinsky IB; Robertson AD; Mehler PS
    Pharmacotherapy; 2003 Jun; 23(6):802-5. PubMed ID: 12820821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients.
    Baker JR; Best AM; Pade PA; McCance-Katz EF
    Ann Pharmacother; 2006 Mar; 40(3):392-6. PubMed ID: 16507617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings.
    Isbister GK; Brown AL; Gill A; Scott AJ; Calver L; Dunlop AJ
    Br J Clin Pharmacol; 2017 Oct; 83(10):2274-2282. PubMed ID: 28488266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physician awareness of the cardiac effects of methadone: results of a national survey.
    Krantz MJ; Rowan SB; Schmittner J; Bucher Bartelson B
    J Addict Dis; 2007; 26(4):79-85. PubMed ID: 18032235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypokalemia in women and methadone therapy are the strongest non-cardiologic factors associated with QT prolongation in an emergency department setting.
    Marill KA; Miller ES
    J Electrocardiol; 2017; 50(4):416-423. PubMed ID: 28274542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methadone and affairs of the heart and of the brain.
    Stimmel B
    J Addict Dis; 2003; 22(3):1-5. PubMed ID: 14621340
    [No Abstract]   [Full Text] [Related]  

  • 36. [Buprenorphine or methadone for detoxification of young opioid addicts?].
    Ebner R; Schreiber W; Zierer C
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S108-10. PubMed ID: 15570521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: A prospective 9-month follow-up study.
    Fredheim OM; Borchgrevink PC; Hegrenaes L; Kaasa S; Dale O; Klepstad P
    J Pain Symptom Manage; 2006 Aug; 32(2):180-5. PubMed ID: 16877186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methadone and torsade de pointes: case report and review of the literature.
    Iskandar SB; Abi-Saleh BS; Mechleb BK; Fahrig SA
    Tenn Med; 2007 Feb; 100(2):35-7, 42. PubMed ID: 17378505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes.
    Krantz MJ; Garcia JA; Mehler PS
    Pharmacotherapy; 2005 Apr; 25(4):611-4. PubMed ID: 15977920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methadone-induced heart arrhythmia].
    Østvold C; Topper M
    Tidsskr Nor Laegeforen; 2005 Aug; 125(15):2021-2. PubMed ID: 16100543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.